| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Maze Therapeutics, Inc.
13G/A
Amendment 1
MAZE · 578784100
|
9.3% |
2/13/2026
Event 12/31/2025
|
|||
| Third Rock Ventures IV, L.P. | 9.3% | ||||
| Third Rock Ventures GP IV, L.P. | 9.3% | ||||
| TRV GP IV, LLC | 9.3% | ||||
| Third Rock Ventures V, L.P. | 2.0% | ||||
| Third Rock Ventures GP V, L.P. | 2.0% | ||||
| TRV GP V, LLC | 2.0% | ||||
|
Tango Therapeutics, Inc.
13D/A
Amendment 4
TNGX · 87583X109
|
4.7% |
2/10/2026
Event 2/6/2026
|
|||
| Third Rock Ventures IV, L.P. | 4.7% | ||||
| Third Rock Ventures GP IV, L.P. | 4.7% | ||||
| TRV GP IV, LLC | 4.7% | ||||
|
Tango Therapeutics, Inc.
13D/A
Amendment 3
TNGX · 87583X109
|
5.9% |
11/21/2025
Event 11/19/2025
|
|||
| Third Rock Ventures IV, L.P. | 5.9% | ||||
| Third Rock Ventures GP IV, L.P. | 5.9% | ||||
| TRV GP IV, LLC | 5.9% | ||||
|
Tango Therapeutics, Inc.
13D/A
Amendment 2
TNGX · 87583X109
|
7.0% |
11/14/2025
Event 11/12/2025
|
|||
| Third Rock Ventures IV, L.P. | 7.0% | ||||
| Third Rock Ventures GP IV, L.P. | 7.0% | ||||
| TRV GP IV, LLC | 7.0% | ||||
|
Maze Therapeutics, Inc.
13G
MAZE · 578784100
|
13.9% |
5/9/2025
Event 1/31/2025
|
|||
| Third Rock Ventures IV, L.P. | 13.9% | ||||
| Third Rock Ventures GP IV, L.P. | 13.9% | ||||
| TRV GP IV, LLC | 13.9% | ||||
| Third Rock Ventures V, L.P. | 2.2% | ||||
| Third Rock Ventures GP V, L.P. | 2.2% | ||||
| TRV GP V, LLC | 2.2% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.